is allulose a glp-1 agonist release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose Evolution of GLP‐1 Receptor Agonists
Description
Various clinical trials have reported these findings, which are discussed further in our study [11-14]
10.1056/NEJMoa2108269 28 GilbertM
J Diabetes Investig (2016) 7:505
Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells
2008;34(Suppl 2):S73-S77
To date, clinical data have been reported for two dual GIP/GLP-1 receptor agonists
